Abraham_Jacob Profile Banner
Jacob Abraham, MD Profile
Jacob Abraham, MD

@Abraham_Jacob

Followers
4K
Following
3K
Media
345
Statuses
2K

Advanced HF/Transplant Cardiologist | SVP Medical Affairs, Edwards LifeSciences Implantable HF Management (IHFM)

Portland, OR
Joined March 2009
Don't wanna be here? Send us removal request.
@Abraham_Jacob
Jacob Abraham, MD
1 year
“H” White’s belief in the importance of giving back is an inspiration. I am honored to have played a role in his care and in the center which now bears his name. Thank you ⁦@HowardHWhite⁩ ⁦@Jumpman23⁩ ⁦ @Nike⁩ ⁦@Ludacris⁩ ⁦@christuckerreal
7
6
51
@MarkBelkinMD
Mark Belkin
3 months
This year we're building on the outstanding hemodynamic questions, providing practical learning for your cath lab, & a look to future innovation! PLUS - 2-day trainee program (Nov 13-14) on hemodynamics, engineering, & a TEACH session, @BurkhoffMd! @EdwardsLifesci @zoll_cms
@ChiHForum
Chicago Hemodynamic Forum
3 months
Save the Date! 📅 The 2nd Annual Chicago Hemodynamic Forum will take place on Friday, November 14th, at UChicago 🫀 Registration is open NOW! https://t.co/4qFNfnUuT0 #Cardiology #Cardiotwitter #HeartFailure #hearthealth #heartdisease
0
12
36
@KristiMasser
kmasser
6 months
Congratulations to the ASCEND fellows! Thank you to the faculty who participated and shared their wisdom and experience over the last three programs. A special thanks to ⁦@shelleyhallmd⁩ ⁦@JeffTeuteberg⁩ and ⁦@AHajduczok⁩ for their passion and leadership! ⁦
2
5
15
@Abraham_Jacob
Jacob Abraham, MD
7 months
🔑 Patients bridged to recovery have low rates of heart replacement post-discharge and 12-month survival 64% "Bridging to recovery" encompasses palliative and therapeutic intent. Future trials need to capture intention of TMCS to place outcomes in context of goals.
1
2
8
@Abraham_Jacob
Jacob Abraham, MD
7 months
Now out in @JCardFail: A prospective, multi-center registry of Impella 5.5 in HF-CS: 🔗 https://t.co/huL8w0IGiV 🔑 Treatment with Impella 5.5 alone vs. multiple MCSD associated with ⬆️ survival and ⬇️complications 🔑 Patients bridged to HRT have 94% survival at 12- months
1
10
37
@MarkBelkinMD
Mark Belkin
7 months
The 1st annual Chicago Hemodynamic Forum was a success! Check out our special report in @CircHF reviewing the inaugural meeting https://t.co/xG8YnDc7K6 We're busy planning for year 2 - agenda coming shortly Save-the-date: Friday, November 14th in Chicago, IL! @ChiHForum
2
17
44
@JasonKatzMD
Jason N. Katz
8 months
I mean seriously….who better to lead a system-wide, multidisciplinary effort around care coordination, delivery, & quality in the CS space than this guy 👇🏼👇🏼👇🏼?!! The answer: there is NO ONE BETTER! A win for @ISHVnews but an even bigger win for all who battle shock!
@ISHVnews
Inova Schar Heart and Vascular
8 months
Excited to announce that CICU Medical Director, @ShashankSinhaMD has been named Director, Cardiogenic Shock, Inova Health System, and will lead system-wide multidisciplinary collaboration and care coordination among key stakeholders in the evaluation and management of Shock
5
10
77
@jjfein
Jason Feinman, MD
8 months
🫀HF-related cardiogenic shock accounts for a growing proportion of CS related admissions to contemporary CICUs 🏥. New data published in @JCardFail from @CCCTNetwork compares patient characteristics, treatments, and outcomes between NICM and ICM in HF-CS
2
16
67
@CVRx_Barostim
CVRx | Barostim
9 months
🎙 New Podcast Episode Released! 📖 Newly published in the @JCardFail and presented at #THT2025, a retrospective analysis using the Premier Healthcare Database (PHD), an all-payer database, demonstrated a large and significant reduction in hospital visits and length of stay in
0
2
6
@AncoraHeart
Ancora Heart
9 months
We wrapped up #THT2025 with an informative session on treating the dilated LV with the #AccuCinch System! Thank you to @UlrichJordeMD, @Reismanmmd, @BurkhoffMd, @dbufmd & @Abraham_Jacob for sharing your expertise and insights on the CORCINCH-HF #clinicaltrial. #cardioX
0
2
2
@RyanTedfordMD
Ryan J Tedford MD
9 months
Insights on PH due to LHD from PROACTIVE study presented by @szalawad at #THT2025 LBCT: significant ⬇️ in MPAP with ARNI titration & ⬆️ if MRA decreased! #GDMTworks #DontStopTheMRA @AndrewJSauer @robmentz @dranulala @ShashankSinhaMD @LiviuKlein Sim pub @JCardFail:
1
11
49
@tonkhueMdPhd
Khue Ton
9 months
👀 our takes on interesting papers in @TheJHLT not featured in past episodes. 👏 #CSWG for continuing to advance the field to win the #waronshock @NavinKapur4 @ElricZweck @lisong2003 @JHMontfort10 @Abraham_Jacob @ShashankSinhaMD @rachkataria @ReshadGaranMD
@TheJHLT
JHLT
9 months
Studies include: - CMR to assess rejection and CAV in #Peds #HeartTx - A simulation framework for #OrganAllocation - The #HeartMate3 Snoopy for noninvasive cardiovascular diagnosis - Acute limb ischemia in #CardiogenicShock
1
5
10
@Endotronix
Endotronix
10 months
Congrats to @Abraham_Jacob, MD, Meegan Mangum, PA and the research team at @ProvHealth on implanting the 1st Cordella™ PA Sensor on the West Coast as part of the PROACTIVE-HF-2 trial. Safety Info: https://t.co/rRUcolKMEB #PRO2 #clinicaltrial #heartfailure #cardiotwitter
0
3
5
@biljana_parapid
Biljana Parapid, MD, PhD, FESC
11 months
0
2
3
@rachkataria
Rachna Kataria, MD
11 months
@Babar_Basir @NavinKapur4 @BurkhoffMd @manreetkanwar @ReshadGaranMD @ShashankSinhaMD @Abraham_Jacob @hfdocbhimaraj @JHMontfort10 Great seeing you last night! Hope you made it home in time for a fun filled Sunday with your family
0
1
4
@EiranGorodeski
Eiran Gorodeski, MD, MPH
11 months
More bad news for Advanced Heart Failure and Transplant Cardiology #NRMP match: Of 75 programs participating in match n=21 (28%) filled. Of 127 positions offered, n=61 (48%) filled. There will only be n=61 AHFTC trainees in the US in 2025-2026 academic year. #ShrinkingWorkforce
22
50
135
@AndrewJSauer
Andrew J Sauer MD
11 months
Limited data are available describing the distribution of the different hemodynamic PH subtypes amongst patients with heart failure using the current guidelines. We analyzed the Hemodynamic Frontiers in Heart Failure Registry, a multicenter database inclusive of consecutive
0
7
13
@CMichaelGibson
C. Michael Gibson MD
11 months
Bumetanide nasal spray safe, has equivalent pharmacodynamic efficacy (urine/sodium output) compared to IV and PO bumetanide administration. View slides here: https://t.co/haNDuPvRn9
3
22
96